齊翔騰達(002408.SZ):2024年淨利潤3167.97萬元 擬10股派0.3元
格隆匯4月9日丨齊翔騰達(002408.SZ)公佈2024年年度報吿,報吿期內,公司全年累計完成化工產品產量341.6萬噸,同比下降1.56%;實現營業收入252.19億元,較上年同期下降6.31%;實現歸屬於上市公司股東的淨利潤3,167.97萬元,較上年同期上升108.26%;實現歸屬於上市公司股東的扣除非經常性損益的淨利潤1,255.72萬元,較上年同期上升104.95%;截止本報吿期末,公司總資產253.61億元,較上年同期下降5.30%,歸屬於上市公司股東的淨資產116.66億元,較上年同期下降1.15%,經營活動產生的現金流量金額13.52億元,同比增長104.59%。向全體股東每10股派發現金紅利0.3元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.